|
CMMI Health IT Learning Event webinars
|
|
|
|
On Nov 18th, Shelly Spiro (Pharmacy HIT Collaborative’s Executive Director) coordinated and presented with ONC the CMMI Health IT Learning Event webinar related to the Enhanced Part D MTM 5-Region Pilot Program. Pharmacy HIT Collaborative members from OutcomesMTM, AMCP, Relay Health and APhA were among the panelist. Almost 500 attendees listened to the webinar. The 2nd webinar is scheduled for Dec 15th (3:00-4:30PM ET) Innovations in HIT-enabled MTM-related care coordination and services.
|
|
|
|
Pharmacists’ Clinical Documentation and Use of SNOMED CT is a Hot Topic
|
|
|
|
On November 6, 2015, the Pharmacy HIT Collaborative submitted comments regarding the proposed 2016 Interoperability Standards Advisory. The Collaborative is supportive of the proposed standards for clinical health IT interoperability purposes. Pharmacists provide patient-centered care and services, maintain various secure patient care records, and as part of the integrated health care team, they are directly involved with other health care providers and patients in various practice settings. Pharmacists are users of health IT and are especially supportive of interoperability standards incorporating HL7, SNOMED CT, LOINC, RxNorm, and NCPDP SCRIPT, and NCPDP Real Time Formulary and Benefits (currently under development).
|
|
|
|
On November 17, 2015, the Pharmacy HIT Collaborative submitted comments in response to CMS request for information regarding implementation of the "Merit-Based Incentive Payment System, Promotion of Alternative Payment Models, and Incentive for Participation in Eligible Alternative Payment Models”. The Collaborative recommends for the benefit of patient care and system efficiencies that pharmacists be included in the list of MIPS eligible professionals (EP).
|
|
|
|
Environmental scan of the use of pharmacogenomic coding
|
|
|
|
Environmental Scan of Pharmacogenomics Coding: Current Practice and Barriers is a paper providing an environmental scan of the use of pharmacogenomic coding by the health care industry. The information is current as of June 1, 2015. Pharmacogenomics has become an important part of the medical conversation and the information allows us to identify which patients may respond to specific treatments or predict which may have increased toxicity, while optimizing drug efficacy and minimizing morbidity and mortality. There are significant challenges in translating pharmacogenomic information into clinical practice, as well as integrating this information in a meaningful way into the electronic health records.
|
|
|
|
Follow @shellyspiro on Twitter
|
|
|
|
|
|
